Orthostatic hypotension due to suppression of vasomotor outflow after amphetamine intoxication

Hypotension, Severe Hyperthermia (42°C), Rhabdomyolysis, and Disseminated Intravascular Coagulation Induced by Lethal Dose of Methamphetamine

Sympathomimetic drug overdose usually results in hypertensive crises, cardiac arrhythmias, rhabdomyolysis, seizures, and metabolic derangements such as hyperglycemia, acidosis, and electrolyte anomalies. Methamphetamine has fast become an increasing problem in the US with an exponential increase in drug-related hospital admissions and an average yearly 29% increase in deaths per year. The recreational dose of methamphetamine is about 5 mg to 60 mg of methamphetamine with lethality reported at around 200 mg. This report presents a fatal case of methamphetamine overdose (>1.5 gms) that presented with hypotension, severe hyperthermia (42.2°C), and rigidity, complicated by rhabdomyolysis, acute renal failure, disseminated intravascular coagulation, and multiorgan failure.

An unusual cause of breathlessness in a young man

Amphetamine abuse is a common problem in the developed world. Cardiomyopathy secondary to amphetamine abuse is rare in the general population. The present report describes a 34-year-old man who presented with shortness of breath. Following further investigations, the cause of his breathlessness was determined to be amphetamine abuse. The incidence of amphetamine abuse and its cardiac sequelae are reviewed. The mechanism of amphetamine-induced dilated cardiomyopathy is analyzed, with further review of its complications and treatment.

Role of epinephrine in acute stress

This article presents the likely pathway of stimuli generated by the recognition of high-intensity stressors to ultimately produce a fight-or-flight response. A key element is the recognition that psychological stressors that do not directly alter the internal environment represent the most important etiology of a fight-or-flight response. Adrenomedullary secretion is a critical component of that response; impromptu stimulation of the adrenal medulla can produce plasma epinephrine concentrations greater than 10,000 pg/mL. When these plasma levels reach the hypothalamus to act on the CNS, the result is facilitation of the decision making, and decision execution processes (fight-or-flight), and perhaps further sympathetic stimulation and vasopressin release. Subjects with underlying cardiovascular and/or metabolic pathology may be particularly susceptible to potentially lethal reactions to this neuroendocrine response. Additionally, since this biological reaction may be triggered by sudden changes in the social environment, the coordinated actions of epinephrine, sympathetic stimulation and vasopressin must be directed at not only optimizing the chances for survival, but also at attaining maximal preservation of the individual environmental and social domains.

Methamphetamine potentiates ischemia/reperfusion insults after transient middle cerebral artery ligation

BACKGROUND AND PURPOSE

Previous studies have indicated that both methamphetamine (MA) and ischemia/reperfusion injuries involve reactive oxygen species formation and activation of apoptotic mechanism. That MA could have a synergistic or additive effect with stroke-induced brain damage is possible. The purpose of the present study was to investigate whether administration of MA in vivo would potentiate ischemic brain injury.

METHODS

Adult CD-1 mice were pretreated with MA or saline. Each animal later was anesthetized with chloral hydrate and placed in a stereotaxic frame. A subset of animals received intracerebral administration of glial cell line-derived neurotrophic factor (GDNF). The right middle cerebral artery and bilateral carotids were transiently occluded for 45 minutes. Regional cerebral blood flow was measured by laser Doppler. Animals were sacrificed for triphenyltetrazolium chloride staining and p53 mRNA Northern blot assay after 24 hours of reperfusion. Cortical and striatal GDNF levels were assayed by ELISA.

RESULTS

We found that pretreatment with MA increased ischemia-induced cerebral infarction. Ischemia or MA alone enhanced p53 mRNA expression. Moreover, MA potentiated expression of p53 mRNA in the ischemic mouse brain. MA pretreatment decreased GDNF levels in ischemic striatum. Intracerebral administration of GDNF before ischemia reduced MA-facilitated infarction.

CONCLUSIONS

Our data indicate that MA exacerbates ischemic insults in brain, perhaps through the inhibition of GDNF-mediated pathways and suggest that MA may antagonize endogenous neuroprotective pathways as part of its mechanism of action.

Pathophysiological mechanisms underlying vasovagal syncope in young subjects

The occurrence of vasovagal fainting is common in young subjects, but the origin of the precipitating hemodynamic mechanisms involved remain a subject of considerable speculation. Vasovagal fainting is not a sudden onset phenomenon, early failure of vascular resistance responses occurs in faint-prone young subjects. The variability of hemodynamic responses during the actual faint is large, but the main mechanism operative during, is withdrawal of sympathetic outflow to blood vessels in skeletal muscle with impairment of ability to maintain vasomotor tone.

Bedside autonomic function testing in patients with vasovagal syncope

The factors that determine the individual susceptibility to vasovagal syncope (VVS) are largely unknown, including the role of the autonomic nervous system. We therefore studied common vagal and sympathetic reflexes in 12 patients with VVS (mean age 37 (18-75) years, 6 men). The Valsalva maneuver and deep breathing were performed to assess vagal responsiveness and mental arithmetic stress; the cold-pressor test and isometric handgrip were performed to assess sympathetic responsiveness. Standing up was performed to assess the combined responsiveness. With the exception of a subnormal response to deep breathing in one patient, all vagal tests were normal. In contrast, the response to mental stress, the cold-pressor test, and isometric handgrip was subnormal in 4 patients, 6 patients, and 4 patients, respectively. The response to standing up was normal in all patients. It is concluded that many patients with VVS are characterized by normal vagal responsiveness, but sympathetic hyporesponsiveness. Sympathetic hyporesponsiveness might explain the inadequate vasoconstruction, which plays an important, early role in VVS.

Neural circulatory control in vasovagal syncope

The orthostatic volume displacement associated with the upright position necessitates effective neural cardiovascular modulation. Neural control of cardiac chronotropy and inotropy, and vasomotor tone aims at maintaining venous return, thus opposing gravitational pooling of blood in the lower part of the body. The present concept of the vasovagal response or "common faint" implicates the development of inappropriate cardiac slowing due to sudden augmentation of efferent vagal activity, and arteriolar dilatation by sudden reduction or cessation of sympathetic activity. The venous pooling associated with lasting orthostatic stress results in development of central hypovolemia. At a certain point during the ongoing reflex adaptation to the hypovolemia in progress, a depressor reflex is set in train. The depressor reflex input along this second "peripheral" afferent pathway is postulated to originate from various sites in the cardiovascular system but remains uncertain. The common faint in humans is of both vaso- and vagal origin; the pure vagal response is less common than its vasodepressor variant. There is strong evidence for an early loss of vasomotor tone in the majority of fainting subjects. Blocking the vagus nerve or cardiac pacing is not of much help in preventing vasovagal syncope; though atropine or pacing may prevent bradycardia in vasovagal fainting, they have never been proven to prevent hypotension. Baroreflex modulation of autonomic outflow remains present during the presyncopal stages until it becomes offset by an opposing depressor reflex with relative bradycardia and relaxation of arterial resistance vessels. The nature of the vasodilatation associated with the vasovagal response has still not been settled.